Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current C1NC34 market cap is 186.97B. The company's latest EPS is USD 5.0580 and P/E is 11.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 38.04B | 39.46B | 40.41B | 39.84B | 42.02B |
| Operating Income | 1.18B | -143M | 1.12B | 1.23B | 665M |
| Net Income | 469M | 45M | 1.16B | 1.15B | 713M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 74.64B | 111.12B | 125.98B | 144.55B | 154B |
| Operating Income | 1.78B | 3.08B | 1.78B | 3.64B | 3.46B |
| Net Income | 1.32B | 1.81B | 1.35B | 1.2B | 2.7B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 84.38B | 84.64B | 82.62B | 83.14B | 82.35B |
| Total Liabilities | 58.97B | 58.69B | 55.56B | 55.68B | 54.94B |
| Total Equity | 25.4B | 25.94B | 27.05B | 27.44B | 27.4B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 40.99B | 68.72B | 78.38B | 76.87B | 84.64B |
| Total Liabilities | 28.3B | 42.76B | 51.35B | 52.63B | 58.69B |
| Total Equity | 12.66B | 25.89B | 26.94B | 24.18B | 25.94B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 7.84B | 8.05B | -456M | 1.72B | 741M |
| Investing | -242M | -1.19B | 852M | -315M | -1.15B |
| Financing | -1.46B | -1.66B | 23M | -1.15B | -2.39B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.48B | 5.5B | 4.21B | 6.26B | 8.05B |
| Investing | -1.53B | -6.96B | -3.3B | -2.92B | -1.19B |
| Financing | 6.83B | 260M | 1.36B | -4.2B | -1.66B |
| Market Cap | 186.97B |
| Price to Earnings Ratio | 11.94 |
| Price to Sales Ratio | 0.21 |
| Price to Cash Ratio | 1.88 |
| Price to Book Ratio | 1.24 |
| Dividend Yield | - |
| Shares Outstanding | 534.2M |
| Average Volume (1 week) | 5 |
| Average Volume (1 Month) | 4 |
| 52 Week Change | -4.50% |
| 52 Week High | 452.76 |
| 52 Week Low | 335.58 |
| Spread (Intraday) | 50.35 (12.59%) |
| Company Name | Centene Corp. |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.centene.com |
| Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
